Author

Haruya Saji

Observed names: H. Saji, Haruya SAJI, 春哉佐治

Institutions: Kanagawa Cancer Center, Yokohama City University

Observed institutions: St. Marianna University School of Medicine, Fujisawa City Hospital, Kanagawa Children's Medical Center, Odawara Municipal Hospital, Kanagawa Cancer Center, Nippon Medical School, Yokohama City University

ORCID: 0000-0003-2770-1731

Observed ORCID: 0000-0003-2770-1731

OpenAlex ID: A5033250321

Losartan and fetal toxic effects

2001 · Haruya Saji, Michiko Yamanaka, et al. · The Lancet · 147

Anxiety and prevalence of psychiatric disorders among patients awaiting surgery for suspected ovarian cancer

2008 · Akiko Sukegawa, Etsuko Miyagi, et al. · Journal of obstetrics and gynaecology research · 28

Survival After Fertility-Preserving Hormonal Therapy vs Hysterectomy for Early-Stage Endometrial Cancer

2025 · Yukio Suzuki, Yongmei Huang, et al. · JAMA Oncology · 12

Effect of storage temperature on nucleic acid quality in formalin-fixed paraffin-embedded tissue samples

2025 · Yoichiro Okubo, Nagisa Toyama, et al. · Annals of Diagnostic Pathology · 10

Awareness of Infectious Disease Screening During Early Pregnancy and Knowledge About its Vertical Transmission in Japan: A Report from the Pregnant Women Health Initiative

2023 · Mizuha Odagami, Akiko Iwata, et al. · Maternal and Child Health Journal · 10

PDF

Impact of germline variants on breast and ovarian cancer risk in Japanese women: an original cohort study and meta-analysis

2025 · Shu Yazaki, Megumi Hori, et al. · EBioMedicine · 8

PDF

Does the extension of the type of hysterectomy contribute to the local control of endometrial cancer?

2019 · Tetsuya Hasegawa, Megumi Furugori, et al. · International Journal of Clinical Oncology · 8

PDF

Crucial immunological roles of the invasion front in innate and adaptive immunity in cervical cancer

2024 · Yuhya Hirahara, Kanako Shimizu, et al. · British Journal of Cancer · 7

PDF

Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study

2024 · Mari Uomoto, Yukihide Ota, et al. · BMC Cancer · 6

PDF

Endometrial Aspiration Cytology for Diagnosis of Peritoneal Lesions in Extrauterine Malignancies

2007 · Haruya Saji, Keisuke Kurose, et al. · Acta Cytologica · 6

Declining Prevalence of Human Papillomavirus Co‐Infections Among Young Japanese Women With Cervical Cancer and Its Precursors

2024 · Eri Yoshiizumi, Mamiko Onuki, et al. · Journal of Medical Virology · 3

PDF

Bulky peritoneal carcinosarcoma with tiny high-grade serous carcinoma of the fallopian tube: a case report

2020 · Ayaka Nakashima, Yasuyo Maruyama, et al. · International Cancer Conference Journal · 3

Optimal adjuvant strategy in intermediate-risk cervical cancer: a systematic review and meta-analysis

2026 · Akira Yokoi, Hiroko Machida, et al. · International Journal of Clinical Oncology · 2

PDF

Long-term survival outcomes for hormonal therapy in premenopausal patients with clinical stage I endometrial cancer.

2024 · Yukio Suzuki, Yongmei Huang, et al. · Journal of Clinical Oncology · 2

Survival impact of pelvic radiotherapy plus chemotherapy in newly diagnosed stage IVB cervical cancer in Japan (JROSG22-1/JGOG1088S)

2026 · Keisuke Tsuchida, Kazunari Ogawa, et al. · Radiotherapy and Oncology · 1

Enhancing the positive predictive value of early-stage ovarian cancer detection using a two-step machine learning framework

2026 · Mikio Mikami, Kazuhiro Tanabe, et al. · Journal of Translational Medicine · 1

943 A single-arm confirmatory trial of postoperative CCRT using IMRT for patients with high-risk uterine cervical cancer (JCOG1402)

2025 · Fumiaki Isohashi, Takafumi Toita, et al. · Radiotherapy and Oncology · 1

345 A case of mixed adenocarcinoma of uterus with bladder invasion originating from adenomyosis

2020 · A. Nakashima, H. Saji, et al. · International Journal of Gynecological Cancer · 1

PDF

Serum KL-6 for diagnosis of ovarian carcinoma associated with dermatomyositis: two case reports and characteristic clinicopathological factors

2012 · Tae Mogami, Haruya Saji, et al. · International Cancer Conference Journal · 1

PDF

Correction: Optimal adjuvant strategy in intermediate-risk cervical cancer: a systematic review and meta-analysis

2026 · Akira Yokoi, Hiroko Machida, et al. · International Journal of Clinical Oncology

PDF

Patterns of Recurrence and Subsequent Treatment After First-line Parp Inhibitor Maintenance in Ovarian Cancer

2026 · Maria Hishida, Aika Genda, et al. · International Journal of Gynecological Cancer

Survival Outcomes of Parp Inhibitor Rechallenge in Recurrent Ovarian Cancer: a Multicenter Retrospective Study in Japan

2026 · Aika Genda, Maria Hishida, et al. · International Journal of Gynecological Cancer

Clinical Benefit of Pembrolizumab in Lynch Syndrome‐Associated Advanced Ovarian Cancer With Germline MSH6 Variant: A Case Report

2026 · Tomomi Yokozawa, Sayako Nakagawa, et al. · Clinical Case Reports

PDF

Molecular residual disease detection for ovarian cancer using a WGS-based ctDNA assay: Initial findings from the MONSTAR-SCREEN-3.

2026 · Fuminori Ito, Hiroshi Tanabe, et al. · Journal of Clinical Oncology

Invasive stratified mucin-producing carcinoma of the uterine cervix masquerading as squamous cell carcinoma on biopsy: a diagnostic pitfall